Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page

Q3 2023 Orthopedics Update

Skip to the end of the Expertise Menu

Q3 2023 Orthopedics Update

Over the past two years, the pressing demands and staffing challenges within the orthopedic industry have underscored the critical need for more efficient operations and improved clinical effectiveness. In response, practices of all sizes have turned to mergers and acquisitions to enhance their clinical services, obtain supporting capital resources, and gain access to state-of-the-art treatment delivery systems. Furthermore, the ongoing encouragement from payors to embrace value-based care models is intensifying the urgency to invest in infrastructure and data tracking capabilities, ultimately driving further M&A activity.

With several private equity backed orthopedic platforms currently on the market, or forthcoming this quarter, Provident expects to see multiple landmark transactions in Q4-2023 and early 2024. These secondary and tertiary transactions will accelerate the pace of subsequent bolt-on acquisitions, as new investors seek to rapidly expand their portfolios during the early stage of their investment holdings.

To print and download the full Orthopedics Update report, please click below…

[holo_button icon=”/wp-content/uploads/2023/10/Q3-23-Orthopedics.pdf”” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]